- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03075098
Colposcopy in Detection of Oral Epithelial Dysplasia
Diagnostic Accuracy Of Colposcopic Examination in Patients With Oral Dysplastic Lesion (Diagnostic Accuracy Study)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A- Roles and Responsibilities:
- The Principle Supervisor: Dr. Mohsen Kazem (M.K.), Professor of Oral &Maxillofacial Pathology, Cairo University, will examine the taken biopsy histopathologically and determine the definitive diagnosis.
- The Assistant Supervisor: Dr. Heba Dahmoush (H.D.), Professor of Oral & Maxillofacial Pathology, Cairo University, will examine the taken biopsy histopathologically and determine the definitive diagnosis.
- The Principle Investigator: Sarah Ahmed Mohamed Mahmoud Badawy (S.B.), Assistant Lecturer of Oral &Maxillofacial Pathology, Cairo University, will read and put a colposcopic score for each participant individually.
- Eman Desouky (E.D.) Sample size calculation; Statistician, Faculty of Oral and Dental Medicine, Cairo University, Egypt.
- Evidence Based Committee, Faculty of Dentistry, Cairo University: Help in reporting study protocol following STARD guidelines.
- Ethics Committee, Faculty of Dentistry, Cairo University: Protocol reviewer of the diagnostic accuracy study in order to protect the right, safety, dignity and well-being of the participants.
B- Index test: The principle investigator (S.B.) will perform the index test using Digital Electronic Colposcope (Kernel, KN-2200, China). Before taking up the patients for Colposcopic evaluation and giving them a score, the normal Colposcopic findings will be standardized based on the Colposcopic criteria. Colposcopic criteria includes aceto uptake, surface pattern and clarity of demarcation of the mucosal lesions, vascular pattern, lesion size as well as Iodine staining.
C- Reference test:The reference standard; to reach a definitive diagnosis in oral dysplastic lesions, will be a representative biopsy and histopathological examination. M.K. and H.D. will examine the taken biopsy histopathologically, determine the definitive diagnosis and write the diagnosis in the Assessor chart.
Inclusion criteria:
- Patients seeking for diagnosis of clinically suspected oral dysplastic Leukoplakia or Erythroplakia
- Patients seeking for diagnosis of clinically suspected oral Carcinoma.
Exclusion criteria:
- Patients with secondary infection.
- Patients having other systemic diseases.
- Patients undergoing treatment for the lesions.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients seeking for diagnosis of clinically suspected oral dysplastic Leukoplakia or Erythroplakia
- Patients seeking for diagnosis of clinically suspected oral Carcinoma.
Exclusion Criteria:
- Patients with secondary infection.
- Patients having other systemic diseases.
- Patients undergoing treatment for the lesions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: colposcopy of intraepithelial carcinoma
Digital colposcope will be used to detect the swede score of the lesion
|
Diagnostic accuracy of colposcopic examination; Swede scoring system will be used to evaluate the colposcopic examination.
Then, the specificity (%) and the sensitivity (%) of colposcopic examination will be calculated using the cutoff value of 8 to segregate dysplastic from non-dysplastic lesions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic accuracy of colposcopic examination
Time Frame: Baseline
|
using digital colposcope (Kernel, KN-2200, China)
|
Baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEBD-CU-2017-03-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intraepithelial Carcinoma
-
Coordinación de Investigación en Salud, MexicoUniversity of Guadalajara; Instituto Mexicano del Seguro SocialCompletedConjunctival Intraepithelial Neoplasia | Corneal Intraepithelial NeoplasiaMexico
-
Brookdale University Hospital Medical CenterUnknownCarcinoma in Situ of Uterine Cervix | Cervical Intraepithelial Neoplasias | High Grade Cervical Intraepithelial NeoplasiaUnited States
-
Krankenhaus Barmherzige Schwestern LinzMedical University of ViennaCompletedCervical Intraepithelial Neoplasia Grade 1 | Cervical Intraepithelial Neoplasia Grade 2Austria
-
Nykode Therapeutics ASATheradex; Vaccibody ASCompletedHigh Grade Cervical Intraepithelial NeoplasiaGermany
-
Medtronic - MITGCompletedAnal Intraepithelial Neoplasia (AIN) | High-grade Squamous Intraepithelial Lesions (HSIL)United States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)CompletedHigh-grade Cervical Intraepithelial NeoplasiaUnited States
-
Genexine, Inc.CompletedCervical Intraepithelial Neoplasia 3Korea, Republic of
-
BioLeaders CorporationUnknownCervical Intraepithelial Neoplasia Grade 2/3Korea, Republic of
-
ViMREX GmbHFrankfurter Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus...CompletedVulvar Intraepithelial Neoplasia Grade 2 | Vulvar Intraepithelial Neoplasia Grade 3Germany
-
University Medical Centre MariborRecruitingCervical Intraepithelial Neoplasia Grade 2 | DNA MethylationSlovenia
Clinical Trials on Digital colposcope
-
British Columbia Cancer AgencyM.D. Anderson Cancer Center; National Cancer Institute (NCI); The University... and other collaboratorsCompletedCervical Cancer | Precancerous ConditionUnited States, Canada
-
Brookdale University Hospital Medical CenterUnknownCarcinoma in Situ of Uterine Cervix | Cervical Intraepithelial Neoplasias | High Grade Cervical Intraepithelial NeoplasiaUnited States
-
Duke UniversityRecruiting
-
Duke UniversityTerminatedCervical Pre-cancerUnited States, Zambia, Tanzania, India, Peru
-
Scripps HealthCompletedCervical CancerUnited States
-
Barretos Cancer HospitalM.D. Anderson Cancer Center; William Marsh Rice University; Irmandade Santa Casa...RecruitingCervical Intraepithelial NeoplasiaBrazil
-
Duke UniversityFogarty International Center of the National Institute of HealthCompleted
-
Zydolab - Institute of Cytology and Immune CytochemistryRuhr University of BochumCompletedUterine Cervical DysplasiaGermany
-
Duke UniversityNational Cancer Institute (NCI); Kenya Medical Research InstituteRecruiting
-
King's College LondonGuy's HospitalCompletedTemporomandibular Disorders (TMD)United Kingdom